Clinical Supply Logistic Articles
-
Putting Vaccine Supply Resilience To The Test: The Last Mile
4/29/2026
This second in a two-part series describes how the resilience of a global vaccine network shaped clinical supply is challenged up to the last mile: at clinical sites.
-
How Clinical Supply Drives Resilience In Global Vaccine Networks
4/29/2026
This article is the first in a two-part series exploring how clinical supply's ability to integrate processes drives resilience in global vaccine programs.
-
From Inconsistency To Structure: A Model For Defensible Compliance Decisions
4/29/2026
Compliance decisions depend on how sponsors, manufacturers, logistics, and brokers align inputs. Structure connects documentation, reducing reconstruction at review.
-
Why Good Data Still Fails: Inconsistency, Visibility, And Decision Risk
4/22/2026
Even with strong visibility clinical supply chains face delays when data is inconsistent across systems. Alignment not more data drives faster, clearer border decisions.
-
Designing CNS Trial Supply Chains: A Technical Framework
4/21/2026
CNS trials demand precision supply chains. From DTP logistics to dynamic forecasting, small disruptions can compromise data, adherence, and outcomes.
-
Primary Healthcare Disruption And Clinical Trial Supply Risk
4/20/2026
Funding cuts are destabilizing primary healthcare systems and exposing hidden risks in clinical trial supply, from cold chain breakdowns to site readiness gaps.
-
Protecting Clinical Trials From Global Supply Disruptions
4/17/2026
Clinical trials are fragile. Supply chain disruptions like cold chain failures or single-source dependencies threaten patient safety and trial success.
-
From Passive To Predictive: The New Era Of Clinical Cold Chain Management
4/16/2026
Temperature-sensitive drugs demand a cold chain that predicts disruptions, manages risks, and coordinates globally to keep trials on time and patients safe.
-
When Shipments Stop: Understanding And Managing Customs Delays In Clinical Supply Chains
4/15/2026
Customs delays aren’t random disruptions. They reveal where documentation, classification, and context fail to align under scrutiny across complex global trials.
-
6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening
4/14/2026
Expert-recommended "once‑in‑a‑lifetime" testing for Lp(a) introduces new clinical supply risks as screening drives volatility, longer treatment, and inventory strain.